RECRUITING

Susan G. Komen's ShareForCures

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

ShareForCures (SFC) is a community-based participatory research registry, and its prime objective is to engage participants representative of the United States breast cancer patient population -including minoritized and historically marginalized people, persons, or communities-to ensure the data researchers use to study breast cancer is as diverse as the people touched by this disease. In doing so, researchers will have a better understanding of breast cancer, and everyone can potentially benefit from scientific advances and improvements in care.

Official Title

ShareForCures: Susan G. Komen's People-powered, Data-driven Breast Cancer Research Registry

Quick Facts

Study Start:2022-11-17
Study Completion:2032-11
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05654246

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Individuals must be at least 18 years old. (Individuals in Alabama and Nebraska must be over 19 and individuals in Mississippi and Pennsylvania must be over 21 to participate).
  2. * Individuals must have been diagnosed with cancer originating (or is suspected to originate) from the breast.
  3. * Individuals must be currently residing in the United States or a territory of the United States.
  4. * Individuals must be able to read and understand English.
  1. * Individuals under the age of 18 years. (Individuals in Alabama and Nebraska under 19 and individuals in Mississippi and Pennsylvania under 21 are not eligible to participate).
  2. * Individuals without a diagnosis of breast cancer.
  3. * Individuals who are not residing in the United States or a territory of the United States.
  4. * Individuals unable to read and understand English.

Contacts and Locations

Study Contact

Jerome Jourquin, Ph.D., M.S.
CONTACT
1-877-465-6636
JJourquin@komen.org

Principal Investigator

Jerome Jourquin, Ph.D., M.S.
PRINCIPAL_INVESTIGATOR
Susan G. Komen

Study Locations (Sites)

Susan G. Komen
Dallas, Texas, 75380
United States

Collaborators and Investigators

Sponsor: Susan G. Komen Breast Cancer Foundation

  • Jerome Jourquin, Ph.D., M.S., PRINCIPAL_INVESTIGATOR, Susan G. Komen

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-11-17
Study Completion Date2032-11

Study Record Updates

Study Start Date2022-11-17
Study Completion Date2032-11

Terms related to this study

Additional Relevant MeSH Terms

  • Breast Cancer